Stockholm Mammography Risk Stratified Trial
SMART is a Phase III, randomised, non-blinded screening trial. Women who consent to participate in SMART are randomised to either individualised screening or screening according to the Swedish National Breast Cancer Screening Program. Women randomised to individualised screening get their 2-year risk of breast cancer assessed and women with the highest short-term risk are offered contrast enhanced mammography and a mammogram at 12 months.
- EligibilityCriteria: Inclusion Criteria:  Have read, understood and signed the informed consent Perform breast cancer screening at Södersjukhuset Females in the age range 40 - 74 years at baseline mammography Using a smartphone or tablet with BankID  Exclusion Criteria:  Pregnant, breast feeding or planning to become pregnant. Previous breast cancer A medical condition that according to the responsible physician would negatively affect the health of the women. Cognitive impairment and / or language ability that would make it difficult for the participant to understand the implication of study and to perform a contrast mammography.  For women that will be offered contrast enhanced mammography the clinically accepted and applied exclusion criteria will be used. Women who cannot perform a contrast mammography will be offered an automated ultrasound. - HealthyVolunteers: Accepts Healthy Volunteers - Gender: Female - GenderBased: Yes - GenderDescription: Registered as a woman in the Swedish social security number system. - MinimumAge: 40 Years - MaximumAge: 74 Years - StdAgeList: Adult, Older Adult